Monday, September 17, 2012 10:04:28 PM
BY DJ Realtime News 12:40 PM ET 09/17/2012
http://stockcharts.com/h-sc/ui?s=JAZZ
Shares of Jazz Pharmaceuticals PLC (JAZZ) jumped 13.2% to $54.47 recently following news that a federal court has issued a Markman ruling largely in favor of Jazz on its narcolepsy medication Xyrem.
"The judge in the Xyrem patent case just issued the long awaited Markman ruling that defines the patent claim terms," wrote Jefferies analyst Corey Davis in his note Monday.
"In our initial read, we count 17 occurrences of agreeing with the Jazz construction and zero occurrences of agreement with Roxane [Laboratories]. We have not had a chance to fully review the 43 page ruling, but at first blush this seems like a clear win for Jazz," Davis added.
Jazz's stock has climbed approximately 12% over the past 30 days and over 41% year-to-date.
Write to Val Brickates Kennedy at vkennedy@marketwatch.com
Recent JAZZ News
- Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024 • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 03:38:33 PM
- Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024 • PR Newswire (US) • 09/09/2024 11:58:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:09:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2024 11:50:34 PM
- Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024 • PR Newswire (US) • 09/05/2024 11:30:00 AM
- Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/04/2024 04:12:00 AM
- Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/04/2024 04:00:00 AM
- Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/03/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 06:27:01 PM
- Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies • PR Newswire (US) • 08/22/2024 08:05:00 PM
- Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences • PR Newswire (US) • 08/21/2024 08:15:00 PM
- Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences • PR Newswire (US) • 08/21/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:45:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:42:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:42:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:40:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:40:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:39:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:39:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:53:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:52:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:50:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:48:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/06/2024 01:57:56 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM